Haemoglobin Decreased
also: Hemoglobin Decreased
89 drugs35,407 FAERS reportsMedDRA PT
GET
/api/v1/reaction/haemoglobin-decreasedReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Haemoglobin Decreased (89)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Mitapivat19227%
- 2Epstein-barr Virus125%
- 3Vitamin K2318%
- 4Tarlatamab114%
- 5Imetelstat2314%
- 6Danicopan2913%
- 7Dibucaine119.6%
- 8Bacillus Subtilis48.5%
- 9Tisagenlecleucel3628.1%
- 10Niraparib1,7437.9%
- 11Sutimlimab217.9%
- 12Glutamate17.7%
- 13Eculizumab3,9047.3%
- 14Pegcetacoplan1207.2%
- 15Pacritinib2017.1%
- 16Vitamin D3156.7%
- 17Vadadustat166.5%
- 18Crovalimab56.2%
- 19Iptacopan406.0%
- 20Luspatercept1355.9%
- 21Phentolamine95.8%
- 22Deferoxamine1205.7%
- 23Cedazuridine435.7%
- 24Colloidal Oatmeal145.6%
- 25Epoetin Alfa7675.6%
- 26Revumenib375.4%
- 27Deferasirox1,4075.4%
- 28Epoetin Beta5835.3%
- 29Methoxy Polyethylene Glycol-epoetin Beta5835.3%
- 30Danazol1475.3%
- 31Daprodustat905.1%
- 32Eptifibatide374.9%
- 33Cefotetan74.9%
- 34Anagrelide1064.7%
- 35Alvimopan24.7%
- 36Talazoparib784.6%
- 37Hydroxyurea9374.5%
- 38Dinoprostone354.4%
- 39Momelotinib514.3%
- 40Ruxolitinib2,9334.2%
- 41Fondaparinux3394.2%
- 42Ribavirin2,6294.1%
- 43Rucaparib3594.1%
- 44Fedratinib534.1%
- 45Belzutifan523.9%
- 46Peginterferon Alfa-2a2,0423.8%
- 47Velmanase Alfa23.7%
- 48Crizanlizumab503.6%
- 49Radium2473.5%
- 50Inavolisib143.5%
- 51Terlipressin103.5%
- 52Voxelotor7523.4%
- 53Dacomitinib253.4%
- 54Amyl Nitrite23.3%
- 55Ravulizumab3833.1%
- 56Darbepoetin Alfa1,6363.1%
- 57Gemtuzumab Ozogamicin1113.1%
- 58Ibritumomab Tiuxetan453.0%
- 59Deferiprone872.9%
- 60Caplacizumab462.8%
- 61Decitabine1352.7%
- 62Pamabrom102.7%
- 63Venetoclax1,5662.6%
- 64Ivosidenib492.6%
- 65Heparin3532.6%
- 66Sipuleucel-t1422.5%
- 67Factor Viia22.5%
- 68Clozapine3,0842.5%
- 69Toremifene102.4%
- 70Alprostadil832.3%
- 71Thymol82.3%
- 72Pirtobrutinib162.3%
- 73Warfarin2,8792.3%
- 74Bedaquiline312.2%
- 75Olaparib4252.1%
- 76Azacitidine6032.1%
- 77Enoxaparin1,1732.1%
- 78Eltrombopag4482.0%
- 79Oxytocin561.9%
- 80Lisocabtagene Maraleucel151.9%
- 81Quizartinib101.8%
- 82Bivalirudin171.8%
- 83Tenecteplase271.8%
- 84Enasidenib531.6%
- 85Magnesium Salicylate141.6%
- 86Tirofiban381.3%
- 87Tetraxetan1361.1%
- 88Vipivotide Tetraxetan1361.1%
- 89Lutetium1911.1%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Platelet Count Decreased41 shared · 0.20
- White Blood Cell Count Decreased21 shared · 0.14
- Anaemia54 shared · 0.11
- Thrombocytopenia27 shared · 0.09
- Haemolysis8 shared · 0.09
- Haemorrhage10 shared · 0.08
- Disease Progression22 shared · 0.07
- Death64 shared · 0.07
- Malignant Neoplasm Progression15 shared · 0.07
- Gastrointestinal Haemorrhage8 shared · 0.07
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.